Business Strategy — Company Profile

Overview

Navadhi Market Research Research Estimate) on the back of government-supported fertility programmes and rising per-capita fertility clinic density. Asian-manufactured alternatives, targeting the premium IVF centre segment where clinical outcome data and physician preference drive procurement decisions above unit price. Eastern distributors, targeting 25–35% of total revenue from B2B manufacturing contracts by 2026 (Navadhi Market Research Research Estimate), reducing dependence on branded end-market sales cycles.

Table of Contents

• Company Overview & Strategy
• Financial Performance (2022–2024)
• Product Portfolio
• SWOT Analysis